Form 8-K - Current report:
SEC Accession No. 0000882095-25-000022
Filing Date
2025-08-04
Accepted
2025-08-04 16:07:16
Documents
13
Period of Report
2025-07-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gild-20250730.htm   iXBRL 8-K 31904
2 AMENDED AND RESTATED BYLAWS, AS AMENDED JULY 30, 2025 gildex31amendedandrestated.htm EX-3.1 294046
  Complete submission text file 0000882095-25-000022.txt   495062

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20250730.xsd EX-101.SCH 1795
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20250730_lab.xml EX-101.LAB 22788
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20250730_pre.xml EX-101.PRE 13056
15 EXTRACTED XBRL INSTANCE DOCUMENT gild-20250730_htm.xml XML 2912
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 251180284
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)